<Publication>
  <id>TUW-203924</id>
  <title>Towards an interoperable information infrastructure providing decision support for genomic medicine</title>
  <abstractText>Genetic dispositions play a major role in individual disease risk and treatment response. Genomic medicine, in which medical decisions are refined by genetic information of particular patients, is becoming increasingly important. Here we describe our work and future visions around the creation of a distributed infrastructure for pharmacogenetic data and medical decision support, based on industry standards such as the Web Ontology Language (OWL) and the Arden Syntax. Keywords. genomic medicine, decision support, interoperability, ontology, Arden Syntax</abstractText>
  <keywords/>
  <authors/>
  <affiliations/>
  <sections>
    <Section>
      <title>Introduction</title>
      <type>deo:Introduction</type>
      <typeEnum>INTRODUCTION</typeEnum>
      <referenceIds/>
      <referenceCitations/>
    </Section>
    <Section>
      <title>1. Methods</title>
      <type>deo:Methods</type>
      <typeEnum>METHOD</typeEnum>
      <referenceIds/>
      <referenceCitations/>
    </Section>
    <Section>
      <title>2. Preliminary results and discussion</title>
      <type>DoCO:Section</type>
      <typeEnum>METHOD</typeEnum>
      <referenceIds/>
      <referenceCitations/>
    </Section>
  </sections>
  <citationContexts/>
  <references>
    <Reference>
      <id>ref47</id>
      <referenceIdString>47</referenceIdString>
      <authors/>
      <referenceText>[1] B.S. Shastry, „Genetic diversity and new therapeutic concepts“, Journal of Human Genetics , vol. 50, 2005, S. 321-328.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref48</id>
      <referenceIdString>48</referenceIdString>
      <authors/>
      <referenceText>[2] F.W. Frueh, S. Amur, P. Mummaneni, R.S. Epstein, R.E. Aubert, T.M. DeLuca, R.R. Verbrugge, G.J. Burckart, und L.J. Lesko, „Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use“, Pharmacotherapy , vol. 28, 2008, S. 992-998.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref50</id>
      <referenceIdString>50</referenceIdString>
      <authors/>
      <referenceText></referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref52</id>
      <referenceIdString>52</referenceIdString>
      <authors/>
      <referenceText></referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref54</id>
      <referenceIdString>54</referenceIdString>
      <authors/>
      <referenceText></referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref55</id>
      <referenceIdString>55</referenceIdString>
      <authors/>
      <referenceText>[6] T. Hernandez-Boussard, M. Whirl-Carrillo, J.M. Hebert, L. Gong, R. Owen, M. Gong, W. Gor, F. Liu, C. Truong, R. Whaley, M. Woon, T. Zhou, R.B. Altman, und T.E. Klein, „The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge“, Nucleic Acids Research , vol. 36, Jan. 2008, S. D913-D918.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref56</id>
      <referenceIdString>56</referenceIdString>
      <authors/>
      <referenceText>[7] D.S. Wishart, „DrugBank and its relevance to pharmacogenomics“, Pharmacogenomics , vol. 9, Aug. 2008, S. 1155-1162.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref59</id>
      <referenceIdString>59</referenceIdString>
      <authors/>
      <referenceText></referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref61</id>
      <referenceIdString>61</referenceIdString>
      <authors/>
      <referenceText></referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref62</id>
      <referenceIdString>62</referenceIdString>
      <authors/>
      <referenceText>[11] A. Coulet, N.H. Shah, Y. Garten, M. Musen, und R.B. Altman, „Using text to build semantic networks for pharmacogenomics“, Journal of Biomedical Informatics , vol. 43, Dez. 2010, S. 1009-1019.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref63</id>
      <referenceIdString>63</referenceIdString>
      <authors/>
      <referenceText>[12] M. Gwinn, D.A. Grossniklaus, W. Yu, S. Melillo, A. Wulf, J. Flome, W.D. Dotson, und M.J. Khoury, „Horizon scanning for new genomic tests“, Genetics in Medicine: Official Journal of the American College of Medical Genetics , Jan. 2011.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref64</id>
      <referenceIdString>64</referenceIdString>
      <authors/>
      <referenceText>[13] S.M. Teutsch, L.A. Bradley, G.E. Palomaki, J.E. Haddow, M. Piper, N. Calonge, W.D. Dotson, M.P. Douglas, und A.O. Berg, „The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group“, vol. 11, Jan. 2009, S. 3-14.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref65</id>
      <referenceIdString>65</referenceIdString>
      <authors/>
      <referenceText>[14] M. Dumontier, B. Andersson, C. Batchelor, C. Denney, C. Domarew, A. Jentzsch, J. Luciano, E. Pichler, E. Prud’hommeaux, P.L. Whetzel, O. Bodenreider, T. Clark, L. Harland, V. Kashyap, P. Kos, J. Kozlovsky, J. McGurk, C. Ogbuji, M. Samwald, L. Schriml, P.J. Tonellato, J. Zhao, und S. Stephens, „The Translational Medicine Ontology: Driving personalized medicine by bridging the gap from bedside to bench“, Proceedings of the 13th Annual Bio-Ontologies Meeting , 2010.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref66</id>
      <referenceIdString>66</referenceIdString>
      <authors/>
      <referenceText>[15] A. Coulet, M. Smaïl-Tabbone, A. Napoli, und M.-D. Devignes, „Suggested Ontology for Pharmacogenomics (SO-Pharm): Modular Construction and Preliminary Testing“, 2006.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref67</id>
      <referenceIdString>67</referenceIdString>
      <authors/>
      <referenceText>[16] K. Eilbeck, S.E. Lewis, C.J. Mungall, M. Yandell, L. Stein, R. Durbin, und M. Ashburner, „The Sequence Ontology: a tool for the unification of genome annotations“, Genome Biology , vol. 6, 2005, S. R44.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref69</id>
      <referenceIdString>69</referenceIdString>
      <authors/>
      <referenceText></referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref70</id>
      <referenceIdString>70</referenceIdString>
      <authors/>
      <referenceText>[18] C.L. Overby, P. Tarczy-Hornoch, J.I. Hoath, I.J. Kalet, und D.L. Veenstra, „Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support“, vol. 11, S. S10-S10.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref72</id>
      <referenceIdString>72</referenceIdString>
      <authors/>
      <referenceText></referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref73</id>
      <referenceIdString>73</referenceIdString>
      <authors/>
      <referenceText>[20] T. Vetterlein, H. Mandl, und K.-P. Adlassnig, „Fuzzy Arden Syntax: A fuzzy programming language for medicine“, Artificial Intelligence in Medicine , vol. 49, Mai. 2010, S. 1-10.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref75</id>
      <referenceIdString>75</referenceIdString>
      <authors/>
      <referenceText></referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
    <Reference>
      <id>ref76</id>
      <referenceIdString>76</referenceIdString>
      <authors/>
      <referenceText>[22] K. Kawamoto, „Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success“, BMJ , vol. 330, 2005, S. 765-0.</referenceText>
      <publication reference="/Publication[1]"/>
    </Reference>
  </references>
</Publication>